According to news on February 21, according to foreign news reports, Kenneth Warner, Honorary Professor of Avedis Donabedian, Honorary University of Public Health, Michigan University, said that sufficient evidence supports the use of electronic cigarettes as a front -line auxiliary means for adult smoking.

"Too many adults who want to quit smoking can't do it," Warner said in a statement. "Electronic cigarettes are the first new tools to help them in decades. However, only relatively few smokers and medical care professionals realize their potential value."

In a study published in the "Nature Medicine" magazine, Warner and his colleagues viewed electronic cigarettes from a global perspective, and studied the country that advocated electronic cigarettes as a smoking quit method and a country that did not promote electronic cigarettes.

This group of authors said that although the United States and Canada agencies acknowledged the potential benefits of using electronic cigarettes, they believed that the evidence of recommending electronic smoking quitting was insufficient.

However, in the United Kingdom and New Zealand, senior management supports and promotes electronic cigarettes as a choice of first -line smoking treatment.

Warner said: We believe that governments, medical groups and personal healthcare professionals in the United States, Canada and Australia should consider the potential of electronic cigarettes in promoting smoking cessation. Electronic cigarettes are not the wounds of destruction caused by smoking, but they can contribute to achieving this lofty public health goal.

Warner's previous studies have found that a large number of evidence shows that electronic cigarettes are an effective smoking cessation tool for adults in the United States, and hundreds of thousands of people die from smoking -related diseases each year.

In addition to evaluating the differences in regulatory activities of various countries, researchers have also studied the evidence of electronic cigarettes to promote smoking quitting, the impact of electronic cigarettes on health, and the impact of clinical care.

They also quoted the US Food and Drug Administration to specify some electronic cigarette brands as suitable for protecting public health -this is the standard required to obtain marketing approval. Researchers said that this action indirectly hinted that FDA believes that electronic cigarettes can help some people who can not do so.

Warner and his colleagues concluded that accepting the promotion of electronic cigarettes as a smoking cessation tool may depend on the continuous efforts to reduce young people who have never smoked and use electronic cigarette products. These two goals should be coexist.

Researchers include Neal Benowitz of the Department of Medicine at the University of California, the Ann Mcneill of the National Intelligence Center of the King of London, and Nancy Rigotti from the Harvard Medical College of Medicine.